loratadine;nortriptyline hydrochloride
- Generic Name
- loratadine;nortriptyline hydrochloride
A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis
Phase 2
Completed
- Conditions
- Plaque Psoriasis
- Interventions
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2009-01-15
- Lead Sponsor
- Zalicus
- Target Recruit Count
- 20
- Registration Number
- NCT00796211
- Locations
- 🇩🇪
ProInnovera, Muenster, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath